NASDAQ: GOSS - Gossamer Bio

Yield per half year: +43.54%
Dividend yield: 0.00%
Sector: Healthcare

Gossamer Bio

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
0/10
0 57.27 -100% -3.69 -100%
P/S 0 33.44 -100%
P/BV 2.11 4.64 -54.55%
P/FCF -1.43 42.53 -103.36%
Ev/Ebitda -1.85 -17.68 -89.55%
Ev/S 0 22.59 -100%
Ev/FCF -1.97 47.55 -104.13%
E/P -0.7901 0.0182 -4441.21%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
0/10
0 -14.2 -100% 0 0%
ROE -286.47 9.78 -3028.38%
ROA -57.65 0.33 -17566.87%
ROIC -60.27 7.63 -889.46%
ROS 0 -26.41 -100%
ROCE -276.82 14.55 -2002.68%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
10/10
-1.25 -3.87 -67.64% -1.1 +13.51%
Nеt Debt/Ebitda -1.06 -4.24 -74.89%
Debt/Ratio 0.6807 0.1853 267.36%
Debt/Equity 53.08 1.61 3204.07%
Debt/Net Income -1.18 10.06 -111.74%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
0/10
0 0.5351 -100% 0 0%
Number of years of dividend growth 0 0.7368 -100%
DSI 0 0.2368 -100%
Average dividend growth 0 1.48 -100%
Average percentage for 5 years 0 0.4863 -100%
Average percentage for payments 0 43.64 -100%
Difference from average difference in sector -0.5351

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
0/10
0 30.62 -100%
Growth impulse Ebitda in 5 years -3.77 -17.42 -78.36%
Growth impulse Net Income in 5 years 0.6814 -52.26 -101.3%
Growth impulse FCF in 5 years 5.12 -31.68 -116.16%
Growth impulse EPS in 5 years -63.86 -61.82 3.3%
IP Score
2.32/10

Similar companies

OrganiGram Holdings

Viveve Medical

Illumina

Nektar Therapeutics

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription